Peptide Solutions Technology Transfer doc and DON

This is a Notice of Intent, not a request for proposal.  The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Peptide Solutions, Tucson, AZ 85747 for GMP DON and technology transfer.

The Lymphocyte Activation Section (LAS) of the Laboratory of Immunogenetics(LIG) of NIAID, Conducts research on the molecular mechanisms underlying the activation of B lymphocytes to proliferate and differentiate into clones of antibody producing cells.

This technology transfer document is needed to facilitate a US FDA registered GMP facility to produce a front run and a feasibilty run of non-GMP material which is used in the creation of a batch manufacturing record which will then facilitate the GMP run.

No Substitutions are allowed on this project.

FAR Provisions that apply:

FAR 52.204-24 Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (Aug 2020)

FAR 52.204-26 Covered Telecommunications Equipment or Services-Representation (Dec 2019)

FAR 52.212-1 Instructions to Offerors Commercial Items (Jun 2020)

FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (Aug 2020)

FAR 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements – Representation (Jan 2017)

FAR 52.212-3 Offerors Representations and Certifications- Commercial Items

FAR 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015)

The Place of performance is 5625 Fishers Lane Rockville, MD 20852. 

The statutory authority for this sole source requirement is 41 U.S.C.1901 (e) (2) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements.

THIS IS NOT A REQUEST FOR QUOTES. 

All responsible sources that could provide comparable services may submit a capability statement that will be considered by email (subject line to reference NOI-NIAID-2035136) to Ms. Skye Duffner at skye.duffner@nih.gov by 10:00 am eastern standard time, September 11, 2020.  All responses received by the closing date of this synopsis will be considered by the Government.  A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.